London, United Kingdom
ZOE, founded in 2017, is a cutting-edge healthcare scale-up poised to make a significant impact through its unique combination of scientific research and artificial intelligence. With the ambitious mission stated in its slogan, "We’re on a mission to improve the health of millions," the company has already garnered a strong foundation of support from top scientists and seasoned entrepreneurs.
ZOE's primary offering is a personalized nutrition program that’s transforming the way individuals conceive a fundamental aspect of life: healthy eating tailored to the body's needs. Its service is currently available in the US and UK, serving tens of thousands of users eager to adopt healthier lifestyles.
Backed by a substantial £5.20M Late VC investment as of December 2025, ZOE continues to benefit from its interdisciplinary expertise across biology, engineering, and nutrition science. The company's dedication to values like inclusivity, transparency, and open-mindedness positions it well for sustainable growth and innovation in its expanding target markets.
